FBXL20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.726800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.001800E-01
Normal-vs-Stage2
7.961000E-01
Normal-vs-Stage3
4.880000E-01
Normal-vs-Stage4
1.642810E-01
Stage1-vs-Stage2
4.422600E-01
Stage1-vs-Stage3
1.047430E-01
Stage1-vs-Stage4
8.750600E-01
Stage2-vs-Stage3
2.965600E-01
Stage2-vs-Stage4
4.507400E-01
Stage3-vs-Stage4
9.725700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.285000E-01
Normal-vs-AfricanAmerican
3.959200E-01
Normal-vs-Asian
7.375000E-01
Caucasian-vs-AfricanAmerican
2.500200E-01
Caucasian-vs-Asian
6.825400E-01
AfricanAmerican-vs-Asian
5.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.700800E-01
Normal-vs-Female
7.946200E-01
Male-vs-Female
8.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.666380E-01
Normal-vs-Age(41-60Yrs)
3.652000E-01
Normal-vs-Age(61-80Yrs)
9.705000E-01
Normal-vs-Age(81-100Yrs)
9.504600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.254000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.938200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.861800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.321600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.820300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.607800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.787400E-01
Normal-vs-Daily Drinker
8.925200E-01
Normal-vs-Weekly Drinker
9.769200E-01
Normal-vs-Occasional Drinker
5.674400E-01
Normal-vs-Social Drinker
4.639000E-01
Non Drinker-vs-Daily Drinker
5.549600E-01
Non Drinker-vs-Weekly Drinker
7.316600E-01
Non Drinker-vs-Occasional Drinker
4.744200E-01
Non Drinker-vs-Social Drinker
4.566200E-01
Daily Drinker-vs-Weekly Drinker
8.454000E-01
Daily Drinker-vs-Occasional Drinker
1.713240E-01
Daily Drinker-vs-Social Drinker
1.419760E-01
Weekly Drinker-vs-Occasional Drinker
2.826600E-01
Weekly Drinker-vs-Social Drinker
2.227800E-01
Occasional Drinker-vs-Social Drinker
9.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.058970E-01
Normal-vs-Grade 2
4.905600E-02
Normal-vs-Grade 3
6.839500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.014400E-01
Grade 1-vs-Grade 3
1.058150E-01
Grade 1-vs-Grade 4
1.058970E-01
Grade 2-vs-Grade 3
4.763600E-01
Grade 2-vs-Grade 4
4.905600E-02
Grade 3-vs-Grade 4
6.839500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.029000E-01
Normal-vs-NonDiabetic
7.210200E-01
Diabetic-vs-NonDiabetic
8.881700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.400800E-01
Normal-vs-NoPancreatitis
8.138600E-01
Pancreatitis-vs-NoPancreatitis
2.008600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.385200E-01
Normal-vs-N1
7.494000E-01
N0-vs-N1
6.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.880200E-01
Normal-vs-TP53-NonMutant
8.647400E-01
TP53-Mutant-vs-TP53-NonMutant
1.379390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
